HTR2C and major depressive disorder: The 5-HT2C agonists represent potential pharmacotherapeutics for the treatments of drug abuse and addiction [4, 9], while agomelatine, which is melatonergic agonist and 5-HT2C antagonist, is effective for treatment of depression with relatively mild side effects [10].